Aura Biosciences: Bringing Not-Quite-Viruses Closer To Fruition In Cancer
Source: SeekingAlpha
2025-11-15 07:09:55 ET
Topline Summary
It has been several years since I took a first look at Aura Biosciences ( AURA ) and their unique light-activated virus-like treatment approach. I found the data they had generated at that time to be "tantalizing," and, obviously, a cool technology. But it was not enough to justify the company's lofty valuation, relative to their holdings....
Read the full article on Seeking Alpha
For further details see:
Aura Biosciences: Bringing Not-Quite-Viruses Closer To Fruition In Cancer
Aura Biosciences Inc.
NASDAQ: AURA
AURA Trading
4.91% G/L:
$7.05 Last:
65,583 Volume:
$7.05 Open:
AURA Latest News
March 30, 2026 07:00:00 am
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
AURA Stock Data
$357,523,404
49,469,047
0.85%
51
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
